Funded Startups in Branford
Among the seven Branford-based funded companies shown, the largest disclosed round is Princeton Medspa Partners’ $120M on 2024-06-11; every other disclosed…
Among the seven Branford-based funded companies shown, the largest disclosed round is Princeton Medspa Partners’ $120M on 2024-06-11; every other disclosed amount falls well below that level (e.g., Saphlux at $44M on 2026-04-07, Azitra at $31M on 2026-03-19, and IsoPlexis at $125M on 2021-10-12). Sector coverage is concentrated: three of the seven entries are biotechnology (Azitra in 2026-03-19, BEKHealth in 2025-01-13, and IsoPlexis in 2021-10-12).
Timing also clusters. Disclosed amounts appear across a broad edge-to-edge window (2021-10-12 through 2026-04-07), but several rounds cluster in mid-2024, including Sachem Capital (2024-06-17), Princeton Medspa Partners (2024-06-11), and an additional June 2024 entry (undisclosed for BEKHealth’s closest neighbor in the list). Stage labeling is uneven: five of the seven rows show “Series Unknown” or “undisclosed” amounts (BEKHealth 2025-01-13 is undisclosed; Sachem Capital 2024-06-17 is undisclosed; DotLab 2023-09-12 is undisclosed; and three rows are marked “Series Unknown”).
Most recent rounds
7 shownRelated listings
Frequently asked
Which disclosed round is the outlier in this Branford list, and how do the others compare?
The biggest disclosed amount is IsoPlexis at $125M on 2021-10-12, which sits above the next-largest disclosed round, Princeton Medspa Partners at $120M on 2024-06-11. The remaining disclosed amounts are notably lower, including Saphlux at $44M (2026-04-07) and Azitra at $31M (2026-03-19).
Do any sectors appear over-represented among these seven entries?
Biotechnology is the clear concentration, showing up in three of the seven companies: Azitra (2026-03-19, $31M), BEKHealth (2025-01-13, undisclosed), and IsoPlexis (2021-10-12, $125M). Other visible singletons include Consumer Electronics (Saphlux) and Data and Analytics (Princeton Medspa Partners).
Are multiple rounds clustered in a narrow date window in Branford?
Yes—there is a mid-2024 cluster with two closely dated entries in June 2024: Princeton Medspa Partners on 2024-06-11 ($120M) and Sachem Capital on 2024-06-17 (amount undisclosed). The list also adds a third adjacent-era “Series Unknown” entry at 2025-01-13 (BEKHealth), extending the concentration beyond a single month.
What proportion of the list has undisclosed amounts or “Series Unknown,” and what are the closest examples?
Five of the seven rows fall into “Series Unknown” and/or “undisclosed” amount patterns: Azitra (Series Unknown, $31M), BEKHealth (Series Unknown, undisclosed), Sachem Capital (Series Unknown, undisclosed), DotLab (Seed but undisclosed), and two additional “Series Unknown” entries (BEKHealth and Sachem Capital). Only Saphlux (Series C, $44M on 2026-04-07) and the 2021 Post-IPO Equity entry (IsoPlexis, $125M on 2021-10-12) provide clearer stage labels with disclosed amounts.
Which entries are within the most recent 90 days of the newest row shown?
Using the latest date shown (2026-04-07 for Saphlux), the rows within roughly the next 90 days are Saphlux (2026-04-07, $44M) and Azitra (2026-03-19, $31M). The next closest entry chronologically is BEKHealth on 2025-01-13 (undisclosed), outside that recent window.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.